A critical role for the Sp1-binding sites in the transforming growth factor-β-mediated inhibition of lipoprotein lipase gene expression in macrophages

Increasing evidence suggests that the cytokine transforming growth factor-β (TGF-β) inhibits the development of atherosclerosis. The lipoprotein lipase (LPL) enzyme expressed by macrophages has been implicated in the pathogenesis of atherosclerosis by stimulating the uptake of lipoprotein particles. Unfortunately, the action of TGF-β on the expression of LPL in macrophages remains largely unclear. We show that TGF-β inhibits LPL gene expression at the transcriptional level. Transient transfection assays reveal that the −31/+187 sequence contains the minimal TGF-β-responsive elements. Electrophoretic mobility shift assays show that Sp1 and Sp3 interact with two regions in the −31/+187 sequence. Mutations of these Sp1/Sp3 sites abolish the TGF-β-mediated suppression whereas multimers of the sequence impart the response to a heterologous promoter. TGF-β has no effect on the binding or steady-state polypeptide levels of Sp1 and Sp3. These results, therefore, suggest a novel mechanism for the TGF-β-mediated repression of LPL gene transcription that involves regulation of the action of Sp1 and Sp3.

[1]  A. Hermetter,et al.  New fluorogenic triacylglycerol analogs as substrates for the determination and chiral discrimination of lipase activities. , 1996, Journal of lipid research.

[2]  J. Gimble,et al.  In vitro and in vivo analysis of murine lipoprotein lipase gene promoter: tissue-specific expression. , 1995, The American journal of physiology.

[3]  D. Ramji,et al.  The pivotal role of lipoprotein lipase in atherosclerosis. , 2002, Cardiovascular research.

[4]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[5]  D. Ramji,et al.  Lipoprotein lipase: structure, function, regulation, and role in disease , 2002, Journal of Molecular Medicine.

[6]  J. Horowitz,et al.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. , 1997, Nucleic acids research.

[7]  S. Deeb,et al.  Sp1 and Sp3 transactivate the human lipoprotein lipase gene promoter through binding to a CT element: synergy with the sterol regulatory element binding protein and reduced transactivation of a naturally occurring promoter variant. , 1998, Journal of lipid research.

[8]  P. Galéra,et al.  Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio. , 2002, Journal of Biological Chemistry.

[9]  J. Massagué,et al.  A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.

[10]  Y. Kook,et al.  Sp1 mediates constitutive and transforming growth factor beta-inducible expression of urokinase type plasminogen activator receptor gene in human monocyte-like U937 cells. , 2000, Biochimica et biophysica acta.

[11]  D. Grainger,et al.  Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice. , 1997, Circulation.

[12]  S. Philipsen,et al.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. , 1999, Nucleic acids research.

[13]  R. Flavell,et al.  Disruption of TGF-β signaling in T cells accelerates atherosclerosis , 2003 .

[14]  M. Ferguson,et al.  Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. , 1992, The Journal of clinical investigation.

[15]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[16]  T. Hughes,et al.  Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines. , 1996, Cytokine.

[17]  L. Ala‐Kokko,et al.  Down-regulation of Human Type II Collagen Gene Expression by Transforming Growth Factor-β1 (TGF-β1) in Articular Chondrocytes Involves SP3/SP1 Ratio* , 2002, The Journal of Biological Chemistry.

[18]  C. Sigmund,et al.  Macrophage-Specific Expression of Human Lipoprotein Lipase Accelerates Atherosclerosis in Transgenic Apolipoprotein E Knockout Mice but Not in C57BL/6 Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[19]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[20]  R. Derynck,et al.  Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. , 2003, The Journal of biological chemistry.

[21]  G. Renier,et al.  Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia. , 2002, Journal of lipid research.

[22]  R. Derynck,et al.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. , 2001, Genes & development.

[23]  G. Berx,et al.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.

[24]  P. Neufer,et al.  Exercise attenuates the fasting-induced transcriptional activation of metabolic genes in skeletal muscle. , 2000, American journal of physiology. Endocrinology and metabolism.

[25]  R. Zechner,et al.  Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[26]  R. Derynck,et al.  Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. , 2000, The EMBO journal.

[27]  M. Reale,et al.  Transforming growth factor β1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells , 1998 .

[28]  D. Radzioch,et al.  High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[29]  R. Derynck,et al.  TGF‐β‐induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation , 2001, The EMBO journal.

[30]  P. Dijke,et al.  Interaction between GC Box Binding Factors and Smad Proteins Modulates Cell Lineage-specific α2(I) Collagen Gene Transcription* , 2001, The Journal of Biological Chemistry.

[31]  Á. Corbí,et al.  Identification of a Critical Sp1 Site within the Endoglin Promoter and Its Involvement in the Transforming Growth Factor-β Stimulation* , 2001, The Journal of Biological Chemistry.

[32]  T. Hughes,et al.  Analysis of the Xenopus laevis CCAAT-enhancer binding protein alpha gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1. , 2001, Nucleic acids research.

[33]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[34]  D. Ramji,et al.  Interleukin-6 represses the transcription of the CCAAT/enhancer binding protein-alpha gene in hepatoma cells by inhibiting its ability to autoactivate the proximal promoter region. , 2003, Nucleic acids research.

[35]  Mayur B. Patel,et al.  Macrophage Lipoprotein Lipase Promotes Foam Cell Formation and Atherosclerosis in Low Density Lipoprotein Receptor-deficient Mice* , 2000, The Journal of Biological Chemistry.

[36]  M. Jinnin,et al.  Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1 , 2004, Oncogene.

[37]  M. Daemen,et al.  Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Brattain,et al.  Sp3 Is a Transcriptional Repressor of Transforming Growth Factor-β Receptors* , 2001, The Journal of Biological Chemistry.

[39]  D. Wallace,et al.  TGF-β1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors , 2004 .

[40]  T. Hughes,et al.  A Novel Role of Sp1 and Sp3 in the Interferon-γ-mediated Suppression of Macrophage Lipoprotein Lipase Gene Transcription* , 2002, The Journal of Biological Chemistry.

[41]  R. Lorenz,et al.  TGF-beta1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. , 2000, American journal of physiology. Heart and circulatory physiology.

[42]  R. Derynck,et al.  Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF‐β , 2000 .

[43]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[44]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[45]  R. Assoian,et al.  Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages. , 1991, The Journal of biological chemistry.

[46]  ZiadMallat,et al.  Inhibition of Transforming Growth Factor-β Signaling Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Mice , 2001 .

[47]  D. Ramji,et al.  Characterisation and developmental regulation of the Xenopus laevis CCAAT-enhancer binding protein β gene , 1998, Mechanisms of Development.

[48]  S. Stefoni,et al.  Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. , 2002, Kidney international.

[49]  C. Argmann,et al.  Transforming Growth Factor-&bgr;1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[50]  G. Renier,et al.  Upregulation of macrophage lipoprotein lipase in patients with type 2 diabetes: role of peripheral factors. , 2000, Diabetes.

[51]  Y. Yazaki,et al.  Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[52]  R. Reeves,et al.  Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-β1* , 2001, The Journal of Biological Chemistry.

[53]  S. Zuckerman,et al.  TGF-β increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-γ , 2001 .

[54]  T. Hughes,et al.  Interferon-gamma stimulates the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2. A potentially novel pathway for interferon-gamma-mediated inhibition of gene transcription. , 2003, The Journal of biological chemistry.